Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Explore a 28-minute webinar presented by Dr. Heather Gibson that delves into the role of host genetics in cancer immunotherapy resistance. Learn about groundbreaking research using F1 crosses of inbred mice with genetically heterogeneous Diversity Outbred and Collaborative Cross mouse models to study response variations in antibody-based immunotherapies. Discover how germline genetics influence anti-tumor immunity and treatment outcomes with immune checkpoint inhibitors (ICI) and targeted immunotherapy, even against genetically identical tumors. Gain insights from Dr. Gibson's expertise, developed through her academic journey from Michigan State University to her current position as Assistant Professor in Oncology at Wayne State University, where she leads research on resistance mechanisms to immune checkpoint inhibitors and anti-tumor antibodies. Healthcare professionals can earn PACE credits through Labroots upon completion of the webinar, valid until October 2026.
